The FDA's ANDA process lets generic drug makers prove their products are equivalent to brand-name drugs without repeating full clinical trials. It's how 90% of U.S. prescriptions are filled at a fraction of the cost.
Learn how Medicare Part D formularies cover generic drugs in 2025, including tiered pricing, the $2,000 out-of-pocket cap, cost-saving tips, and what's changing next year.
Cost-effectiveness analysis reveals how generic drugs save billions, but hidden pricing practices often block the best savings. Learn how ICERs, PBMs, and outdated models distort real value in generic drug choices.
State laws determine whether pharmacists must or can choose to give you generic drugs instead of brand-name ones. These rules affect your costs, adherence, and safety. Mandatory substitution saves money and improves outcomes-here’s how they differ across states.
Prescribing generic drugs carries hidden legal risks. With manufacturers shielded from liability, physicians now face rising malpractice claims when patients are harmed. Learn how to protect yourself with proper documentation and prescribing practices.
